527 related articles for article (PubMed ID: 26973210)
1. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
3. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
4. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
5. Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.
Choy H; Shyr Y; Cmelak AJ; Mohr PJ; Johnson DH
Cancer; 2000 Mar; 88(6):1336-46. PubMed ID: 10717614
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer treatment in New Zealand: physician's attitudes.
Christmas T; Findlay M
N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
[TBL] [Abstract][Full Text] [Related]
7. Does knowledge guide practice? Another look at the management of non-small-cell lung cancer.
Raby B; Pater J; Mackillop WJ
J Clin Oncol; 1995 Aug; 13(8):1904-11. PubMed ID: 7636532
[TBL] [Abstract][Full Text] [Related]
8. Treatment patterns in non-small-cell lung cancer in USA: results of the CancerMPact Survey 2018.
Robinson D; Hawthorne S; Zhao L; Hanson M; Kanas G; Davis C; Clark O
Future Oncol; 2020 Mar; 16(7):255-262. PubMed ID: 32019323
[No Abstract] [Full Text] [Related]
9. Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice.
Evison M; Edwards J; McDonald F; Popat S
Clin Oncol (R Coll Radiol); 2020 Aug; 32(8):527-536. PubMed ID: 32216979
[TBL] [Abstract][Full Text] [Related]
10. Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection.
Tanner NT; Gomez M; Rainwater C; Nietert PJ; Simon GR; Green MR; Silvestri GA
J Thorac Oncol; 2012 Feb; 7(2):365-9. PubMed ID: 22237260
[TBL] [Abstract][Full Text] [Related]
11. Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Ramnath N; Dilling TJ; Harris LJ; Kim AW; Michaud GC; Balekian AA; Diekemper R; Detterbeck FC; Arenberg DA
Chest; 2013 May; 143(5 Suppl):e314S-e340S. PubMed ID: 23649445
[TBL] [Abstract][Full Text] [Related]
12. Perceptions of prognosis, treatment, and treatment impact on prognosis in non-small cell lung cancer.
Perez EA
Chest; 1998 Aug; 114(2):593-604. PubMed ID: 9726750
[TBL] [Abstract][Full Text] [Related]
13. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
14. Timing of Thoracic Radiation Therapy With Chemotherapy in Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
Clin Lung Cancer; 2018 Nov; 19(6):e815-e821. PubMed ID: 29857969
[TBL] [Abstract][Full Text] [Related]
15. Radical Treatment of Stage II Non-small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes.
Dudani S; Zhu X; Yokom DW; Yamada A; Ho C; Pantarotto JR; Leighl NB; Zhang T; Wheatley-Price P
Clin Lung Cancer; 2018 Jan; 19(1):e11-e18. PubMed ID: 28711384
[TBL] [Abstract][Full Text] [Related]
16. Treatment Decision Drivers in Stage III Non-Small-Cell Lung Cancer: Outcomes of a Web-Based Survey of Oncologists in the United States.
Cotarla I; Boron ML; Cullen SL; Spinner DS; Faulkner EC; Carroll MC; Shah S; Yagui-Beltran A
JCO Oncol Pract; 2020 Oct; 16(10):e1232-e1242. PubMed ID: 32552457
[TBL] [Abstract][Full Text] [Related]
17. Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea.
Song S; Chang JH; Kim HJ; Kim YS; Kim JH; Ahn YC; Kim JS; Song SY; Moon SH; Cho MJ; Youn SM
Cancer Res Treat; 2017 Jul; 49(3):688-694. PubMed ID: 27809459
[TBL] [Abstract][Full Text] [Related]
18. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
19. [New therapeutic strategies and current research in inoperable locally advanced non small-cell lung cancers (stage IIIB)].
Le Cesne A; Arriagada R; Grunenwald D; Baldeyrou P; Girard P; Bretel JJ; Le Chevalier T
Bull Cancer; 1997 Apr; 84(4):413-9. PubMed ID: 9238166
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and therapeutic approaches to lung cancer in Canada and their costs.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Br J Cancer; 1995 Nov; 72(5):1270-7. PubMed ID: 7577481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
